Breaking News
Get 45% Off 0
🚪 May's AI-picked stock list about to go live. Opportunity is knocking...
Unlock Stocks
Close

GSK plc (GS71)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
17.04 +0.33    +1.97%
29/04 - Closed. Currency in EUR
  • Volume: 12
  • Bid/Ask: 17.11 / 17.30
  • Day's Range: 16.70 - 17.24
Type:  Equity
Market:  Germany
ISIN:  GB00BN7SWP63 
S/N:  A3DMB5
GSK plc 17.04 +0.33 +1.97%

GSK plc Company Profile

 
Read the GSK plc company profile to learn more about the business and the management team. View GSK plc facts about how many employees GSK plc has, GSK company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

68629

Equity Type

ORD

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, infectious, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, inflammation, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop vaccines for influenza and COVID-19, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.

Contact Information

Address 79 New Oxford Street
London, WC1A 1DG
United Kingdom
Phone 44 20 8047 5000
Fax -

Top Executives

Name Age Since Title
Jonathan Richard Symonds 66 2019 Non-Executive Chairman
Hal V. Barron 63 2018 Non-Executive Director
Anne C. Beal 63 2021 Independent Non-Executive Director
Elizabeth McKee Anderson 68 2022 Independent Non-Executive Director
Harry C. Dietz 67 2022 Independent Non-Executive Director
Emma Natasha Walmsley 56 2011 CEO & Director
Jesse L. Goodman 74 2016 Scientific & Medical Expert and Independent Non-Executive Director
Wendy Mira Becker 60 2023 Independent Non-Executive Director
Tsun-Huei Lee 61 2024 Scientific & Medical Expert and Independent Non-Executive Director
Charles A. Bancroft 66 2020 Senior Independent Non-Executive Director
Vishal Sikka 58 2022 Independent Non-Executive Director
Julie Belita Brown 63 2023 CFO & Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK plc (GSK) Price Discussion

Write your thoughts about GSK plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Reshad Chesson
Reshad Chesson Mar 19, 2025 12:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
constant hammering by 2 hedge funds, why
Taj Khan
Taj Khan Jan 07, 2025 9:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GlaxoSmithKline (GSK) A new article has been published – GSK’s GSK’227 Receives FDA Breakthrough Therapy Designation for Osteosarcoma
Mike Bamber
Mike Bamber Nov 15, 2024 14:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well, as I have said repeatedly over the last few years, GSK is a train crash under CEO Walmsley. GSK had a reputation as the world's leading vaccine developer. Along came COVID and GSK was never in the running. They had an offer of £50bln for the now Haleon and turned it down. Haleon was spun off at half the offer price to the detriment of shareholders. Now GSK is being widely downgraded as an underperforming pharma company and the share price is dropping through the floor while it's closest rival Astrazenica has tripled in value over the last 8 years. The only upside is GSK has settled most Zantac claims, yet the share price still falls. I'm afraid until we get a change of CEO nothing will improve. Train Crash!
Reshad Chesson
Reshad Chesson Oct 03, 2024 16:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it's a screaming buy
Reshad Chesson
Reshad Chesson Oct 01, 2024 9:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
as soon as zantac litigation solved 2200 target
Reshad Chesson
Reshad Chesson Oct 01, 2024 8:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looks like gsk has been bombed in lebanon
Evangelos Ballas
Evangelos Ballas Jul 31, 2024 9:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any reason why its down after todays string resumts?
Elliot oscar Hervard denney
Elliot oscar Hervard denney Jul 31, 2024 9:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Due to less sales than expected in vaccines and one of their products peforming poorly in america. They are also in a lawsuit regarding their heartburn medicines.
Mike Bamber
Mike Bamber Jul 24, 2024 12:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GSK is a total train crash under current CEO.
Ka Boom
Ka Boom May 10, 2024 12:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will it exceed 1800 and stay their is the question
Ka Boom
Ka Boom May 10, 2024 12:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
more enough 5 year high. now will it smash through that high is the question.....
Reshad Chesson
Reshad Chesson Jan 31, 2024 13:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nov 1 call coming correct
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email